Patient Care

11.28.23

by ASTCT Science Highlights

11.16.23

by ASTCT Science Highlights

11.14.23

by ASTCT Science Highlights

11.03.23

by ASTCT Science Highlights

$T-cell Replete Cord Transplants Give Superior Outcomes in High-risk and Relapsed/refractory Pediatric Myeloid Malignancy$

10.31.23

by Alex Kadhim

$Allogeneic CAR4-DNTs to target relapsed/refractory T-cell malignancies$

10.31.23

by ASTCT Science Highlights

$Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma$

10.25.23

by Alex Kadhim

10.24.23

by ASTCT Science Highlights

10.18.23

by ASTCT Science Highlights

THANK YOU TO OUR SPONSORS